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ABSTRACT 
Cadmium is a toxic metal classified as human carcinogen and ubiquitously found in our 
environment mainly from anthropogenic activities. Exposure to cadmium has been 
associated with increased risk of certain hormone-dependent cancers in humans, and the 
metal has been proposed to possess endocrine disruptive properties by mimicking the 
physiological actions of estrogens. However, the mechanisms behind these effects are 
unclear. The overall aim of this thesis was to provide mechanistic insights into the 
estrogenicity of cadmium that may have implications for the human health. To achieve 
this aim, investigations on the estrogen-like effects of cadmium as well as possible 
involvement of classical/non-classical estrogen receptor signaling was studied in mice, 
and these mechanisms were further scrutinized in cell-based models. Furthermore, 
associations of biomarker of cadmium exposure with endogenous circulating sex 
hormones were evaluated in a population-based study of women. 
Results presented here indicate that exposure to cadmium does not affect the genomic 
estrogen response in vivo in mice, suggesting that classical estrogen signaling is not 
targeted by cadmium. However, some estrogen-like effects were observed in cadmium 
exposed mice, i.e. significant thickening of uterine epithelia, in the absence of uterine 
weight increase, and activation of ERK1/2 MAPKs in the liver. This suggests the 
existence of alternative signaling pathways modulated by cadmium. In addition, 
exposure to a wide dose range of cadmium, dose-dependently increased the expression 
of the endogenous genes Mt1, Mt2, p53, c-fos, and Mdm2 in mouse liver, with p53 being 
the most sensitive gene. However, phosphorylation of ERK1/2 was already induced at 
the lowest exposure level (0.5µg/kg body weight), rendering ERK1/2 a more sensitive 
marker of exposure than any change in gene expression. Furthermore, in vivo findings 
suggest that cadmium-induced effects are markedly concentration dependent: low-level 
exposure activates protein-kinases whereas high-level exposure turns on cellular stress 
responses. The data from in vitro studies indicate that cadmium at regular human 
exposure levels activates protein-kinase signaling through Raf-MEK-ERK/MAPKs, and 
we identified EGFR and GPR30 as the mediating receptors. This cadmium-induced 
activation of protein-kinases further leads to a disturbance in Mdm2/p53 balance, with a 
significant increase in the Mdm2/p53 ratio in the presence of genotoxic compounds, 
which in turn suggest that cadmium may disrupt stress response to genotoxins. In 438 
postmenopausal women, a positive association was observed between the concentrations 
of cadmium in blood and testosterone in serum, while an inverse association was 
observed with estradiol. This may suggest that cadmium affects steroidogenesis. 
In conclusion, data presented in this thesis collectively suggests that cadmium-induced 
estrogen-like effects do not involve classical estrogen receptor signaling but rather 
appear to be mediated via membrane-associated signaling. The activation/ 
transactivation of GPR30/EGFR-Raf-MEK-ERK/MAPKs and Mdm2 represent a general 
mechanism by which cadmium may exert its effects. Since EGFR, ERK and Mdm2 are 
all known key players in cancer promotion, cadmium-induced activation of these and 
disturbance in the estradiol/testosterone balance in women may have implications for the 
promotion/development of hormone-related cancers. 
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